In Stock: Fulphila Biosimilar to Neulasta (Pegfilgrastim-jmdb) 6mg/0.6mL Syringe (Click Here)
Prevention of Chemotherapy-Induced Neutropenia
– 6 mg SC once per chemotherapy cycle, beginning at least 24 hours after completion of chemotherapy
– Do not administer in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy.
Hematopoietic Radiation Injury Syndrome (Acute)
– 6 mg SC once weekly for 2 doses
Manufacturer: Mylan
Find a Physician:
